Israel's DreaMed gets FDA clearance for diabetes solution
Israeli company DreaMed Diabetes AI developed Advisor Pro, a decision support system to assist healthcare providers in the management of diabetes patients with insulin pumps or injections.
A blood glucose test is done to check sugar levels in a Type 2 Diabetes patient(photo credit: DARRYL LEJA/NIH/FLICKR)ByZEV STUB
